View Older Stories
-
BioMarin to Participate in Three Upcoming Investor Conferences
-
Today's most important initiations
-
Pre-Open Stock Movers 08/19: (MNTA) (HUD) (IMVT) Higher; (BMRN) (GLPG) (VIPS) Lower (more...)
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to 'Street High' $148 at Citi; Seen as 'Gene-Therapy Powerhouse' and Takeout Candidate
-
Citi Assumes BioMarin Pharmaceutical Inc. (BMRN) at Buy
-
BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $120 at Citi
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $108 at Citi
-
Spark Therapeutics (ONCE) Should Not Trade Higher on Biomarin (BMRN) Heme Data Update - Citi
-
BioMarin Pharma (BMRN) Should Not Be Selling Off on Heme Data - Citi
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $100 at Citi Following 4Q
-
Blue Ridge 13F Shows New Stake in Ulta (ULTA), GNC (GNC), Increase in Visa (V) (More...)
-
Citi Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
-
BioMarin to Attend Upcoming Investor Conferences
-
Notable Analyst Rating Changes 12/8: (JNPR) (HES) (COR) Upgraded; (FIT) (AZZ) (ARCX) Downgraded
-
Notable Analyst Rating Changes 11/7: (PAH) (BIIB) (CMI) Upgraded; (GPRO) (PNR) (BMRN) Downgraded
-
BioMarin to Attend Three Upcoming Investor Conferences
-
BioMarin to Attend Upcoming Investor Conferences
-
Streetinsider.com's Hot Lunchtime Reads 12/18: (MSFT) (FXCM) (BMRN) (TK)
-
Notable Mergers and Acquisitions 8/24: (SO)/(GAS) (MDVN)/(BMRN) (CIE) (MRKT) (DVA)
-
Notable Analyst Rating Changes 2/9: (MOS) (PFE) (AMC) Upgraded; (CENX) (ANF) (RF) Downgraded
-
Griffin's Blue Ridge Capital 13F Shows New Stake in Alibaba (BABA)
-
Notable Analyst Rating Changes 11/3: (AMTD) (CCI) (BMRN) Upgraded; (AUY) (SE) (DO) Downgraded
-
BioMarin to Present at Upcoming Investor Conferences
-
Griffin's Blue Ridge Capital 13F Shows New MasterCard (MA), Visa (V) Stakes (more...)
-
Griffin's Blue Ridge Capital Shows New Stakes in Allegion (ALLE), Castlight Health (CSLT), Myriad Genetics (MYGN), Walgreen (WAG) (more...)
-
BioMarin to Present at Two Upcoming Investor Conferences in New York
-
Blue Ridge Capital Enters Apple (AAPL), Twitter (TWTR) (more...)
-
Griffin's Blue Ridge Capital Enters 3D Systems (DDD), Tesla (TSLA), BlackBerry (BBRY)
-
BioMarin Pharma (BMRN) Surges as Roche May Make Bid (ALXN)
-
Griffin's Blue Ridge Enters Avis (CAR), LinkedIn (LNKD); Ups Citi (C), Cuts Gilead (GILD) (more...)
-
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
-
Notable Analyst Rating Changes 06/29: (SKS) (BBBY) (ORCL) Upgraded; (RIMM) (NKE) (ANTH) Downgraded
-
Citi Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
-
Notable Analyst Rating Changes 09/28: (BMRN) (LEAP) (MAS) Upgraded; (BZ) (BPO) (KMB) Downgraded
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Citi Moves Myriad Genetics (MYGN) to 'Hold/High Risk'; Over-Reliance on BRACAnalysis
-
Citi Maintains a 'Hold' Rating on Auxilium Pharmaceuticals (AUXL); Prefers BMRN
-
Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)
-
Notable Analyst Rating Changes of the Day 02/08: HD, AMZN, ARAY, WGO Upgraded; BMRN, ARG, HK Downgraded
-
Notable Analyst Rating Changes 1/7: BAC, SHLD, THC, IT, ZUMZ, CITP Upgraded; RAI, AA, RAD, WEN, BEXP Downgraded
-
Citi Upgrades BioMarin Pharmaceutical (BMRN) to Buy; Compelling Valuation
-
Unusual 11 Mid-Day Movers 2/19: WFMI, GRT, S, APAC Higher; ABR, BMRN, FITB, LDK Lower
-
Notable Analyst Rating Changes 2/19: HPQ, CMCSA, WFMI, SU Upgraded; XOM, JAKK, BMRN Downgraded
-
David Moenning's Daily State of the Markets: 2/19
-
Citi Downgrades BioMarin Pharmaceutical (BMRN) to Hold, Citing Disappointing Guidance
-
Citi Upgrades BioMarin Pharmaceutical (BMRN) to Buy
-
Pre-Open Movers 6/12: Lehman (LEH) Sinks After CFO and COO Fired; Applied Biosystems (ABI) Up on Buyout
-
Citi Downgrades BioMarin Pharmaceutical (BMRN) to Hold
-
Notable Analyst Rating Changes 1/29: ARQL, POT, ESLR, TM Upgraded; MCD, NMX, DIS, PMI Downgraded

